Infectious complications in heart transplant patients
نویسندگان
چکیده
Methods 37 patients who underwent orthotopic heart transplantation have been followed for a period of five years. Posttransplantation screening has been performed over the following etiological agents: CMV, hepatitis B virus, hepatitis C virus, Epstein-Barr virus and Toxoplasma gondii. Receptors with criteria for CMV IgG and Toxoplasma IgG antibodies have been accepted. Infectious episodes at 1, 6 and 12 months and evolution depending on CMV screening results, correlated with infection, acute rejection and allograft vessel disease have been pursued. Microbiological techniques, echocardiography, chest X-ray and endomyocardial biopsy have been performed for diagnosis.
منابع مشابه
Effect of neurologic complications on outcome after heart transplant.
OBJECTIVE To study neurologic complications after heart transplant. DESIGN Retrospective cohort study. SETTING Cardiac transplant program at Mayo Clinic, Rochester, Minnesota. PATIENTS We retrospectively studied 313 patients who underwent heart transplant at Mayo Clinic Rochester from January 1, 1988, through October 31, 2006. MAIN OUTCOME MEASURES Neurologic symptoms, neurologic compli...
متن کاملOsteoporosis after stem cell transplantation
Background Stem cell transplantation has become as a novel treatment for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. Improved survival of transplant recipients has raised awareness of post-transplant complications. One of these complications is transplant-related osteoporosis. Methods In this manuscript we review prevention methods for transplant-relat...
متن کاملInfectious complications after heart transplantation in Chinese recipients.
Several factors appear to influence the incidence and type of infectious complications among different populations of transplant recipients. This study sought to assess the incidence and type of infection after transplantation in Chinese heart allograft recipients. A total of 130 infectious episodes occurred in 192 consecutive heart transplantation patients between June 1993 and May 2004. The m...
متن کاملRituximab Is Indispensable for Pediatric Heart Transplant Recipients Developing Post transplant Lymphoproliferative Disorders
Abstract Rituximab, an anti-CD20 agent, has been suggested as an effective strategy to deal with post transplant lymphoproliferative disorders (PTLD). In the current study, we aim to evaluate the efficacy of rituximab therapy in heart transplant population developing PTLD. A comprehensive search of the literature was performed to gather the available data on lymphoproliferative disorders oc...
متن کاملDrug therapy in the heart transplant recipient: Part III: common medical problems.
Continued improvement in the long-term survival of heart transplant recipients has resulted in a population of patients with prolonged exposure to immunosuppressive drugs.1 This exposure, coupled with the increasing age of recipients, has resulted in an impressive prevalence of comorbidities in these patients. Indeed, by 5 years after transplantation, 95% of recipients have hypertension, 81% ha...
متن کاملRespiratory complications after solid-organ transplantation.
The risk for respiratory complications after solid-organ transplantation continues to be high, even though progress has been achieved with surgical techniques, immunosuppressive agents, and perioperative treatment of transplant recipients. This review is an overview of infectious and noninfectious respiratory complications in liver, kidney, heart, and lung transplant patients. Postoperative res...
متن کامل